Harbour BioMed raises $85M in Series B funding round
The company has been busy forming development and commercialization partnerships with other firms to develop antibodies in oncology and rheumatology.
European drug regulator to cut activities ahead of move to Amsterdam
European Medicines Agency faces greater loss of staff than anticipated, forcing it to scale back or suspend some activities.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Dutch bispecific antibody developer nets $18.7 million from US, European VCs
Lava Therapeutics nets 16 million euros in Series B round and plans to decide on clinical drug candidate in oncology this year.
Philips acquires VitalHealth to boost population health management strategy
In an effort to improve its foothold in the population health space, Philips has acquired VitalHealth, which provides cloud-based population health management solutions. Financial details of the deal were not disclosed.
In Brexit aftermath, European Medicines Agency will relocate to Amsterdam
The decision comes at a time of regulatory upheaval in the European Union.
With the $1.7B Spectranetics deal, Philips bolsters therapy business
Royal Philips is pushing further into the therapy business with its purchase of Spectranetics, a Colorado Springs company, that makes image-guided catheters that deliver laser energy to treat blockages in the peripheral vascular region.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Wolters Kluwer paying $170M for patient engagement firm Emmi Solutions
The all-cash deal will give Wolters Kluwer a more complete suite of health information products and allow Emmi to gain a foothold in international markets.
Philips launches line of clinically validated consumer health devices
The launch is the first in a planned series of personal health programs aimed at empowering older, at-risk patients to get healthy and prevent chronic diseases.
Mucosis brings in $4M for development of first RSV vaccine
Dutch biotech company, Mucosis, announced on Wednesday that it secured a $4 million fund awarded from the Wellcome Trust foundation. This will go toward clinical trials – a phase I dose-finding and safety study, followed by a novel phase II challenge study to assess the efficacy for its respiratory syncytial virus (RSV) intranasal vaccine called SynGEM. […]
Ultimaker producing 3D printed models of MRI and CT brain scans
Observing a 2D image of a brain tumor can be challenging for patients to interpret and difficult to translate for doctors. Having 3D printed models of MRI and CT scans can make it easier to understand and approach treatment options.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Discovering Health Care, Not Sick Care
It’s becoming fashionable to say that health care is really ‘sick care’ but who is really trying to work out what caring for health means? One group in the Nijmegen Area of the Netherlands is leading the charge and I was lucky enough to speak with its chief organiser, Chantal Walg. Pritpal S Tamber: Hi […]
MDxHealth buys liquid biopsy prostate cancer test for $8.8M
MDxHealth, the maker of prostate cancer diagnostics, just acquired Dutch liquid biopsy company NovioGendix for $8.8 million. With the new urine-based test, slated for release next year under the name SelectMDx, it aims to reduce unnecessary biopsies for prostate cancer.
AbGenomics developing monoclonal antibody-based psoriasis treatment, raises $13.6M
A Bay Area startup is harnessing the haute monoclonal antibody technology to develop treatment for psoriasis, cancers and inflammatory disease, and is likely about to kick off some serious late-stage efficacy trials. AbGenomics is in the midst of a $24.5 million fundraising round, according to regulatory filings, and has raised $13.2 million to date. The company […]
Dutch company Bioneedle is working on the tiniest vaccine you’ve ever seen
See that tiny, pen-looking piece of polymer Gijsbert van de Wijdeven is holding with tweezers in this image? That’s how Bioneedle Technologies Group is hoping to help public health take a giant step forward. Actually, that’s just one piece of it. The Netherlands-based company has developed what it thinks is a way to make transporting […]
BSX pays out to OrbusNeich to settle stent lawsuit woes
Boston Scientific (BSX) has agreed to make an undisclosed, one-time payment to OrbusNeich to settle all stent-based litigation. This includes settling lawsuits in the United States, the Netherlands, Ireland, Germany and the UK. OrbusNeich is a vascular medical devices company with headquarters in Hong Kong and U.S. offices in Ft. Lauderdale, Fla. In May, OrbusNeich […]